7 research outputs found

    Response of lymphocyte subsets and cytokines to Shenyang prescription in Sprague-Dawley rats with tongue squamous cell carcinomas induced by 4NQO

    Get PDF
    BACKGROUND: The study was designed to investigate immunocompetence in relation to cancer progression in rat and to assess the effect of the traditional Chinese anti-cancer medicine, "Shenyang" prescription, on immunity. METHODS: 4-Nitroquinoline-1-oxide (4NQO) was administered to 80 Sprague-Dawley (SD) rats via the drinking water for up to 36 weeks. Tongue squamous cell carcinoma (SCC) was confirmed by pathological examination in 61 rats. "Shenyang" prescription was administered to subgroups of these rats, and blood samples were taken before and after treatment. Lymphocyte subsets were determined by flow cytometry. Serum Th1 and Th2-type cytokines were assessed by an enzyme-linked immunosorbent assay. RESULTS: As the cancer progressed at the tongue root, the percentage of CD3+CD4+ T lymphocytes and NK cells and the levels of IFN-γ and IL-2 decreased gradually, while the percentage of CD3+CD8+ T lymphocytes and the levels of IL-4 and IL-10 increased. The CD4+/CD8+ ratios were lower in the cancer groups than in the control group. However, after administering "Shenyang" prescription, the levels of CD3+CD4+ T lymphocytes, NK cells, IFN-γ and IL-2 increased, while the CD3+CD8+ T lymphocyte counts and the levels of IL-4 and IL-10 decreased. CONCLUSION: 4NQO-induced lesions were good models for exploring oral cavity carcinogenesis. The rats with 4NQO-induced SCC demonstrated abnormalities in lymphocyte subsets and a shift from Th1-type to Th2-type, which were good models for assessing the effect of anticancer agent on immunity. Oral cancer progression was associated with an aggressive disturbance of immune function. "Shenyang" prescription has the ability to improve the disturbance of immune function

    The effects of swilling an l(−)-menthol solution during exercise in the heat

    No full text
    We have previously demonstrated that provision of a cold fluid (4 degrees C) during exercise in the heat increases fluid intake and improves exercise capacity when compared to a control fluid (19 degrees C). The present study investigated whether these positive effects could simply be replicated with a cooling agent, menthol. Nine healthy, non-acclimatised males (25 +/- 7 years; .VO(2max): 54 +/- 5 ml kg(-1) min(-1)) cycled to exhaustion at 65% of their peak aerobic power output at 34 degrees C, swilling 25 ml of either an L: (-)-menthol (0.01%) or orange-flavoured placebo solution every 10 min, whilst water was available ad libitum; all fluids were kept at 19 degrees C. Eight out of nine subjects cycled for longer whilst swilling with menthol and this resulted in a 9 +/- 12% improvement in endurance capacity. Rectal temperatures rose by 1.7 degrees C during exercise with the same time course in both conditions, whilst skin temperature remained largely unchanged. Swilling with menthol resulted in hyperventilation by 8 +/- 10 L min(-1) and reduced central (cardiopulmonary) ratings of perceived exertion by 15 +/- 14%. No differences between trials were observed for heart rate, oxygen uptake or carbon dioxide production, blood concentrations of glucose or lactate, sweat rate or volume of water ingested. We conclude that a change in the sensation of oropharyngeal temperature during exercise in the heat significantly affects endurance capacity, ventilation and the (central) sense of effort
    corecore